We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+8.1%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$4.28B
AUM Growth
+$1.61B
Cap. Flow
+$1.47B
Cap. Flow %
34.31%
Top 10 Hldgs %
18.89%
Holding
824
New
73
Increased
254
Reduced
178
Closed
177

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$89.1M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$85.1M
3
AMZN icon
Amazon
AMZN
+$53.1M
4
MSFT icon
Microsoft
MSFT
+$52.8M
5
META icon
Meta Platforms (Facebook)
META
+$49.2M

Sector Composition

Rank Sector Weight
1 Healthcare 17.14%
2 Financials 12.35%
3 Technology 12.23%
4 Communication Services 10.2%
5 Consumer Discretionary 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCL icon
226
Royal Caribbean
RCL
$78.7B
$3.88M 0.09%
38,366
+12,130
+46% +$1.16M
PEP icon
227
PepsiCo
PEP
$186B
$3.79M 0.09%
37,934
+989
+3% +$98.7K
JAZZ icon
228
Jazz Pharmaceuticals
JAZZ
$15.9B
$3.73M 0.09%
26,545
-6,650
-20% -$922K
URI icon
229
United Rentals
URI
$71.1B
$3.59M 0.08%
49,495
+14,700
+42% +$1.06M
DGX icon
230
Quest Diagnostics
DGX
$25.1B
$3.56M 0.08%
50,101
+34,567
+223% +$2.32M
CAL icon
231
Caleres
CAL
$396M
$3.54M 0.08%
132,068
-2,030
-2% -$59.1K
MET icon
232
MetLife
MET
$61B
$3.39M 0.08%
78,905
-3,774
-5% -$166K
ABT icon
233
Abbott
ABT
$180B
$3.37M 0.08%
75,130
+705
+0.9% +$31.1K
HP icon
234
Helmerich & Payne
HP
$3.53B
$3.37M 0.08%
62,975
+23,073
+58% +$1.28M
AAL icon
235
American Airlines Group
AAL
$9.58B
$3.34M 0.08%
78,803
+499
+0.6% +$21.6K
REGN icon
236
Regeneron Pharmaceuticals
REGN
$68.8B
$3.26M 0.08%
5,999
+518
+9% +$281K
TGNA
237
DELISTED
TEGNA Inc
TGNA
$3.25M 0.08%
198,973
+134,692
+210% +$2.28M
NGG icon
238
National Grid
NGG
$82.7B
$3.03M 0.07%
45,180
-22,763
-34% -$1.54M
PRXL
239
DELISTED
Parexel International Corp
PRXL
$2.96M 0.07%
43,400
+11,956
+38% +$778K
NWL icon
240
Newell Brands
NWL
$2.16B
$2.92M 0.07%
66,359
+4,165
+7% +$182K
ORCL icon
241
Oracle
ORCL
$331B
$2.92M 0.07%
79,969
+1,359
+2% +$51.9K
GNC
242
DELISTED
GNC Holdings, Inc.
GNC
$2.91M 0.07%
93,903
+65,097
+226% +$2.19M
SYK icon
243
Stryker
SYK
$127B
$2.76M 0.06%
29,655
+8,635
+41% +$826K
INVN
244
DELISTED
Invensense Inc
INVN
$2.7M 0.06%
+264,359
New +$2.93M
IBM icon
245
IBM
IBM
$202B
$2.69M 0.06%
20,436
-62,839
-75% -$8.44M
AVGO icon
246
Broadcom
AVGO
$1.82T
$2.62M 0.06%
180,180
-5,230
-3% -$68K
FL
247
DELISTED
Foot Locker
FL
$2.55M 0.06%
39,163
-179,012
-82% -$11.9M
SPY icon
248
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$2.54M 0.06%
12,440
-836
-6% -$172K
MINT icon
249
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
$2.52M 0.06%
25,061
+387
+2% +$39K
ATW
250
DELISTED
Atwood Oceanics
ATW
$2.41M 0.06%
235,251
-17,521
-7% -$268K

Similar funds

Boston Advisors's Q4 2015 Portfolio in Review

As of Q4 2015, Boston Advisors held 824 positions worth $4.28B, up 60% from $2.67B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Boston Advisors deployed $1.47B of net new capital in Q4 2015, opening 73 new positions and adding to 254 existing holdings. Its largest new stake was Helen of Troy: 237,650 shares worth $22.4M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $20.5M trimmed.

  • Boston Advisors's largest Q4 2015 buy was Helen of Troy: 237,650 shares worth $22.4M.
  • Boston Advisors added most to Apple in Q4 2015, an estimated $89.1M increase.
  • Boston Advisors's biggest Q4 2015 reduction was iShares Russell 2000 ETF, cutting an estimated $20.5M.
  • Boston Advisors fully exited Hasbro in Q4 2015, selling an estimated $11.9M.
  • Boston Advisors's ten largest holdings make up 19% of its $4.28B portfolio in Q4 2015.
  • Boston Advisors opened 73 new positions and closed 177 in Q4 2015.
  • Boston Advisors's portfolio value rose 60% quarter-over-quarter to $4.28B.

Based on Boston Advisors's 13F filing for Q4 2015, filed 20 Jan 2016.